Denalo, Zion .
HRN: 16-28-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/03/2025
10/10/2025
IV
1.5g
Q6hours
T/c Croup
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes